308 related articles for article (PubMed ID: 17878236)
1. A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells.
Condemine W; Takahashi Y; Le Bras M; de Thé H
J Cell Sci; 2007 Sep; 120(Pt 18):3219-27. PubMed ID: 17878236
[TBL] [Abstract][Full Text] [Related]
2. PML regulates p53 stability by sequestering Mdm2 to the nucleolus.
Bernardi R; Scaglioni PP; Bergmann S; Horn HF; Vousden KH; Pandolfi PP
Nat Cell Biol; 2004 Jul; 6(7):665-72. PubMed ID: 15195100
[TBL] [Abstract][Full Text] [Related]
3. Contribution of the C-terminal regions of promyelocytic leukemia protein (PML) isoforms II and V to PML nuclear body formation.
Geng Y; Monajembashi S; Shao A; Cui D; He W; Chen Z; Hemmerich P; Tang J
J Biol Chem; 2012 Aug; 287(36):30729-42. PubMed ID: 22773875
[TBL] [Abstract][Full Text] [Related]
4. PML protein association with specific nucleolar structures differs in normal, tumor and senescent human cells.
Janderová-Rossmeislová L; Nováková Z; Vlasáková J; Philimonenko V; Hozák P; Hodný Z
J Struct Biol; 2007 Jul; 159(1):56-70. PubMed ID: 17428679
[TBL] [Abstract][Full Text] [Related]
5. Patient mutations alter ATRX targeting to PML nuclear bodies.
Bérubé NG; Healy J; Medina CF; Wu S; Hodgson T; Jagla M; Picketts DJ
Eur J Hum Genet; 2008 Feb; 16(2):192-201. PubMed ID: 17957225
[TBL] [Abstract][Full Text] [Related]
6. Expression and localization of Werner syndrome protein is modulated by SIRT1 and PML.
Vaitiekunaite R; Butkiewicz D; Krześniak M; Przybyłek M; Gryc A; Snietura M; Benedyk M; Harris CC; Rusin M
Mech Ageing Dev; 2007; 128(11-12):650-61. PubMed ID: 17996922
[TBL] [Abstract][Full Text] [Related]
7. A novel GTPase, CRAG, mediates promyelocytic leukemia protein-associated nuclear body formation and degradation of expanded polyglutamine protein.
Qin Q; Inatome R; Hotta A; Kojima M; Yamamura H; Hirai H; Yoshizawa T; Tanaka H; Fukami K; Yanagi S
J Cell Biol; 2006 Feb; 172(4):497-504. PubMed ID: 16461359
[TBL] [Abstract][Full Text] [Related]
8. The tumor suppressor SHIP1 colocalizes in nucleolar cavities with p53 and components of PML nuclear bodies.
Ehm P; Nalaskowski MM; Wundenberg T; Jücker M
Nucleus; 2015; 6(2):154-64. PubMed ID: 25723258
[TBL] [Abstract][Full Text] [Related]
9. Role of nuclear bodies in apoptosis signalling.
Krieghoff-Henning E; Hofmann TG
Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of component exchange at PML nuclear bodies.
Weidtkamp-Peters S; Lenser T; Negorev D; Gerstner N; Hofmann TG; Schwanitz G; Hoischen C; Maul G; Dittrich P; Hemmerich P
J Cell Sci; 2008 Aug; 121(Pt 16):2731-43. PubMed ID: 18664490
[TBL] [Abstract][Full Text] [Related]
11. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3.
Fu C; Ahmed K; Ding H; Ding X; Lan J; Yang Z; Miao Y; Zhu Y; Shi Y; Zhu J; Huang H; Yao X
Oncogene; 2005 Aug; 24(35):5401-13. PubMed ID: 15940266
[TBL] [Abstract][Full Text] [Related]
12. Two-step colocalization of MORC3 with PML nuclear bodies.
Mimura Y; Takahashi K; Kawata K; Akazawa T; Inoue N
J Cell Sci; 2010 Jun; 123(Pt 12):2014-24. PubMed ID: 20501696
[TBL] [Abstract][Full Text] [Related]
13. PRIMA-1(MET) induces nucleolar accumulation of mutant p53 and PML nuclear body-associated proteins.
Rökaeus N; Klein G; Wiman KG; Szekely L; Mattsson K
Oncogene; 2007 Feb; 26(7):982-92. PubMed ID: 16909106
[TBL] [Abstract][Full Text] [Related]
14. Nuclear body formation and PML body remodeling by the human cytomegalovirus protein UL35.
Salsman J; Wang X; Frappier L
Virology; 2011 Jun; 414(2):119-29. PubMed ID: 21489587
[TBL] [Abstract][Full Text] [Related]
15. Recruitment of human cytomegalovirus immediate-early 2 protein onto parental viral genomes in association with ND10 in live-infected cells.
Sourvinos G; Tavalai N; Berndt A; Spandidos DA; Stamminger T
J Virol; 2007 Sep; 81(18):10123-36. PubMed ID: 17626080
[TBL] [Abstract][Full Text] [Related]
16. Characterization of endogenous human promyelocytic leukemia isoforms.
Condemine W; Takahashi Y; Zhu J; Puvion-Dutilleul F; Guegan S; Janin A; de Thé H
Cancer Res; 2006 Jun; 66(12):6192-8. PubMed ID: 16778193
[TBL] [Abstract][Full Text] [Related]
17. Identification of RNF168 as a PML nuclear body regulator.
Shire K; Wong AI; Tatham MH; Anderson OF; Ripsman D; Gulstene S; Moffat J; Hay RT; Frappier L
J Cell Sci; 2016 Feb; 129(3):580-91. PubMed ID: 26675234
[TBL] [Abstract][Full Text] [Related]
18. PML positively regulates interferon gamma signaling.
El Bougrini J; Dianoux L; Chelbi-Alix MK
Biochimie; 2011 Mar; 93(3):389-98. PubMed ID: 21115099
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the Zac1's transactivation and coactivation functions via PML and Daxx within distinct subcellular localizations.
Ho CL; Huang YC; Tai CK; Liu ST; Wang JK; Wang WM; Huang SM
Int J Biochem Cell Biol; 2010 Jun; 42(6):902-10. PubMed ID: 20097304
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.
Sivachandran N; Sarkari F; Frappier L
PLoS Pathog; 2008 Oct; 4(10):e1000170. PubMed ID: 18833293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
